Actualités Regeneron Pharmaceuticals Inc - 0R2M | Actions London Stock Exchange

Regeneron, Roche drug cocktail reduces Covid-19 viral load - UK study

Regeneron Pharmaceuticals Inc and Roche Holding AG on Thursday said a drug cocktail the pair have developed "signific ...

Sanofi, Regeneron's Dupixent works for children with atopic dermatitis

Sanofi SA and Regeneron Pharmaceuticals Inc on Monday said a phase 3 trial of Dupixent in children with atopic derma ...

AstraZeneca partners with Regeneron to research obesity treatment

Anglo-Swedish pharmaceutical firm AstraZeneca PLC on Tuesday announced a collaboration agreement with New York-based ...

Roche and Regeneron's Covid antibody cocktail gets Japan approval

Roche Holding AG and Regeneron Pharmaceuticals Inc said Tuesday that Japan has become the first country to approve it ...

Sanofi, Regeneron report well-established safety profile of Dupixent

Paris-based pharma firm Sanofi SA and American biotech company Regeneron Pharmaceuticals Inc on Monday said EU regula ...

Sanofi and Regeneron's cancer treatment Libtayo gets approval in EU

Sanofi SA and Regeneron Pharmaceuticals Inc said Friday the European Commission has approved their PD-1 inhibitor Lib ...

TOP NEWS: Novartis, Regeneron Covid antibody cocktail excels in trials

Novartis AG and Regeneron Pharmaceuticals Inc on Tuesday said their antibody cocktail - casirivimab and imdevimab - r ...

Regeneron, Sanofi report positive phase three trial results of Libtayo

Regeneron Pharmaceuticals Inc and Sanofi SA on Monday reported positive results demonstrating an overall survival ben ...

EU Medicines Regulator Approves Regeneron Coronavirus Therapy

Europe's medicines regulator on Friday provisionally approved use of US biotech firm Regeneron Pharmaceuticals Inc's ...

Roche, Regeneron Note Positive Findings For REGEN-COV In Covid-19

Roche Holding AG and Regeneron Pharmaceuticals Inc on Thursday noted changes to a phase 3 trial of REGEN-COV in non-h ...

IN BRIEF: Sanofi, Regeneron Get US FDA Approval For Lung Cancer Drug

ron Pharmaceuticals Inc - pharmaceutical companies- Says the US Food & Drug Administration approves Libtayo as a treat ...

Roche Says US To Buy Extra Doses Of Regeneron's Covid Antibody Coctail

Roche Holding AG on Tuesday confirmed that the US Department of Health & Human Services and the Department of Defense ...

Regeneron Pharmaceuticals Developing Nasal Spray To Prevent Covid-19

Scientists at the University of Pennsylvania and the biotech firm Regeneron Pharmaceuticals Inc are investigating whe ...

Sanofi And Regeneron Announce New Dupixent Approval In Children

Sanofi SA and Regeneron Pharmaceuticals Inc announced that their drug Dupixent, the brand name for dupilumab, has bee ...

Sanofi, Regeneron Say Dupixent Lowers Esophagitis Symptoms

Sanofi SA and Regeneron Pharmaceuticals Inc on Monday said it has seen additional positive results from Part A of a P ...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Regeneron Pharmaceuticals Inc (0R2M)

Votre Hub pour des idées et discussions en direct en temps réel

0R2M Actualités

Regeneron, Roche drug cocktail reduces Covid-19 viral load - UK study

Sanofi, Regeneron's Dupixent works for children with atopic dermatitis

AstraZeneca partners with Regeneron to research obesity treatment

Roche and Regeneron's Covid antibody cocktail gets Japan approval

Sanofi, Regeneron report well-established safety profile of Dupixent

Sanofi and Regeneron's cancer treatment Libtayo gets approval in EU

TOP NEWS: Novartis, Regeneron Covid antibody cocktail excels in trials

Regeneron, Sanofi report positive phase three trial results of Libtayo

EU Medicines Regulator Approves Regeneron Coronavirus Therapy

Roche, Regeneron Note Positive Findings For REGEN-COV In Covid-19

IN BRIEF: Sanofi, Regeneron Get US FDA Approval For Lung Cancer Drug

Roche Says US To Buy Extra Doses Of Regeneron's Covid Antibody Coctail

Regeneron Pharmaceuticals Developing Nasal Spray To Prevent Covid-19

Sanofi And Regeneron Announce New Dupixent Approval In Children

Sanofi, Regeneron Say Dupixent Lowers Esophagitis Symptoms

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Regeneron Pharmaceuticals Inc (0R2M) Actualités

Regeneron Pharmaceuticals Inc (0R2M)

Votre Hub pour des idées et discussions en direct en temps réel

0R2M Actualités

Regeneron, Roche drug cocktail reduces Covid-19 viral load - UK study

Sanofi, Regeneron's Dupixent works for children with atopic dermatitis

AstraZeneca partners with Regeneron to research obesity treatment

Roche and Regeneron's Covid antibody cocktail gets Japan approval

Sanofi, Regeneron report well-established safety profile of Dupixent

Sanofi and Regeneron's cancer treatment Libtayo gets approval in EU

TOP NEWS: Novartis, Regeneron Covid antibody cocktail excels in trials

Regeneron, Sanofi report positive phase three trial results of Libtayo

EU Medicines Regulator Approves Regeneron Coronavirus Therapy

Roche, Regeneron Note Positive Findings For REGEN-COV In Covid-19

IN BRIEF: Sanofi, Regeneron Get US FDA Approval For Lung Cancer Drug

Roche Says US To Buy Extra Doses Of Regeneron's Covid Antibody Coctail

Regeneron Pharmaceuticals Developing Nasal Spray To Prevent Covid-19

Sanofi And Regeneron Announce New Dupixent Approval In Children

Sanofi, Regeneron Say Dupixent Lowers Esophagitis Symptoms

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application